Diagnos (TSE:ADK) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
DIAGNOS Inc., a Canadian AI-driven healthcare technology company, announced the successful re-election of its board directors and the re-appointment of its auditor following its recent shareholders meeting. Additionally, the company gained shareholder approval for an increase in the stock option plan by 2,000,000 shares, subject to TSX Venture acceptance.
For further insights into TSE:ADK stock, check out TipRanks’ Stock Analysis page.